Stergiopoulos, S., Karabinis, A., Mandragos, K., Komnos, A., Soukup, J., Speelberg, B., & Kirkham, A. (2004). The safety of remifentanil administered for up to 5 days in ICU patients with neurotrauma. BioMed Central.
Παραπομπή Chicago StyleStergiopoulos, S., A. Karabinis, K. Mandragos, A. Komnos, J. Soukup, B. Speelberg, και A. Kirkham. The Safety of Remifentanil Administered for Up to 5 Days in ICU Patients With Neurotrauma. BioMed Central, 2004.
Παραπομπή MLAStergiopoulos, S., et al. The Safety of Remifentanil Administered for Up to 5 Days in ICU Patients With Neurotrauma. BioMed Central, 2004.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.